The ATF/CREB family of eukaryotic transcription factors contain the bZIP structural motif and mediate their transcriptional activities via heterodimerization with ATF and AP-1 family members. Quenching of CREBassociated proteins by a dominant-negative CREB (KCREB) that is mutated within its DNA-binding domain decreases radiation resistance of human melanoma cells. The purpose of this study was to determine the role of CREB in tumor growth and metastasis of human melanoma using KCREB. Highly metastatic MeWo human melanoma cells were transfected with the KCREB expression vector and subsequently analysed for changes in their tumorigenic and metastatic potential. Expression of KCREB in MeWo human cells decreased their tumorigenic and metastatic potential in nude mice compared with parental and control transfected cells. The KCREB-transfected cells displayed downregulation of 72 kDa collagenase type IV (MMP-2) mRNA expression and activity and decreased invasiveness through Matrigel-coated ®lters. Moreover, transcriptional activities mediated by the CAT gene driven by the MMP-2 promoter were decreased by 14 ± 45-fold in KCREB-transfected cells. In addition, the cell-surface adhesion molecule MCAM/MUC18 that is involved in metastasis of human melanoma was downregulated in the KCREB-transfected cells. These data indicate that, through their transcriptional activities, CREB and its associated proteins play an important role in the acquisition of the metastatic phenotype of human melanoma cells.
Introduction
The development of malignant melanomas in humans progresses through a multistage process. During recent years, the discrete steps of this progression have been increasingly better de®ned at the molecular level (reviewed in Lu and Kerbel, 1994) . The switches from melanocyte to nevi, to radial growth and subsequently to a vertical growth phase (metastatic phenotype) are associated with decreased dependence on growth factors, diminished anchorage dependence and reduction of contact inhibition (reviewed in Fidler, 1990) .
One window into the molecular control of melanoma progression has come from extensive study of mitogens. In culture, melanocytes synergistically respond to a number of growth factors, which in combination with each other or with TPA or cAMP stimulate not only proliferation but also pigmentation (Halaban, 1993) . These growth factors include several ®broblast growth factors (FGFs), hepatocyte growth factor or scatter factor (HGF/SF) and stem cell factor (SCF, also known as KIT-ligand, MGF and steel factor), all of which stimulate receptor tyrosine kinases. Since melanocyte proliferation and dierentiation are positively regulated by agents that increase cAMP (Halaban et al., 1983; 1984; , we have focused on the transcription factor CREB (for CRE-binding protein) which is known to be activated by cAMP, as a possible mediator of tumor growth and metastasis of human melanoma cells.
The 43 kDa CREB, which binds the consensus motif 5'-TGACGTCA-3' and activates transcription, was initially isolated from rat brain tissue Bilezikjian, 1987, Yamamoto et al., 1998) and found to be ubiquitously expressed (Borelli et al., 1992) . CREB belongs to the leucine zipper class of proteins, of which at least nine members are known to date (Landschultz et al., 1988; Borreli et al., 1992) . Certain leucine zipper family members can form heterodimers in speci®c combinations; however, the functional signi®cance of this speci®c pairing is unknown. The carboxy terminus of CREB contains a leucine zipper that is required for dimerization and DNA binding (Vinson et al., 1989) . CREB also has a transactivation domain that contains several independent regions, including one identi®ed as the kinase-inducible domain (KID). The KID contains consensus phosphorylation sites for several kinases, including protein kinase A (Borrelli et al., 1992) . Indeed, one of the known mechanisms of CREB transciptional activation is phosphorylation of Ser-133 by the catalytic subunit of cAMP-activated protein kinase A (Roesler et al., 1988) . Recently, P90 RSK and Rsk 2 were identi®ed as potential activators of CREB (Bohm et al., 1995; Xing et al., 1996) . It has been suggested that phosphorylation events alter the conformation of the transactivation domain of CREB, enhancing its interaction with the transcriptional machinery (Hunter and Karin, 1992) .
Previous studies have demonstrated that CREB expression correlates directly with the metastatic potential of murine melanoma cells (Rutberg et al., 1994) . Whether these observations are causally related to tumorigenicity and metastasis of melanoma cells is not yet clear. To study the contribution of the CREB transcription factor to tumor growth and metastasis of human melanoma cells, we used a dominant-negative cDNA construct of CREB, KCREB, that had been mutated in the DNA-binding domain. When over-expressed, this protein can quench factor(s) capable of associating with CREB. CREB-associated proteins were previously shown to include c-jun and ATF2 (Hai and Curran, 1991; Abdel-Malek et al., 1993; Wanda et al., 1991) . As such expression of the KCREB mutant would be expected to yield proper heterodimerization with CRE-binding proteins, yet; owing to the mutant's poor a®nity to DNA, the associated proteins would not confer the same degree of transcriptional activity as they would in the case of the wild-type CREB. For example, previous studies using the KCREB construct in F9 teratocarcinoma and CA-77 thyroid carcinoma cells demonstrated its ability to block cAMP-induced transcription from the somatostatin promoter (Woloshin et al., 1992; Walton et al., 1992) .
Recently, Yang et al. (1996) have reported the isolation and characterization of human melanoma clones derived from the highly metastatic melanoma cell line MeWo that overexpress the dominant negative KCREB construct. The KCREB transfected clones displayed a marked increase in radiation resistance and a poor ability to form colonies in soft agar. In addition, nuclear extracts from KCREB expressing cells failed to interact with the CRE-DNA element on a gel shift mobility assay (Yang et al., 1996) . Here we analysed the eect of KCREB expression on tumor growth and metastatic potential. We show that expression of KCREB in MeWo cells decreased their tumorigenic and metastatic potential in nude mice. KCREB-transfected cells exhibited a signi®cant decrease in 72 kDa collagenase type IV (MMP-2) mRNA expression and activity and in invasiveness through the basement membrane, an important component in the process of tumor invasion and metastasis. Moreover, transcriptional activities mediated by the CAT reporter gene driven by the MMP-2 promoter (which itself contains a CRE-like element) were decreased by 14 ± 45-fold in KCREB-transfected cells. In addition, the melanoma associated antigen MCAM/MUC18 was also downregulated in KCREB transfected cells. These data demonstrate that the transcription factor CREB and its associated proteins are involved in MMP-2 and MCAM/MUC18 gene transcription and hence play an important role in the acquisition of the metastatic phenotype in human melanoma cells.
Results
Tumor growth and metastasis of melanoma cells expressing KCREB Previously, Yang et al. (1996) , have reported the selection and characterization of the MeWo clones K-2 and K-10 which express the dominant-negative mutant KCREB. The K-2 and K-10 clones displayed a tenfold decrease in radiation resistance and ®vefold reduction in their ability to form colonies in soft agar compared with control MeWo parental and neotransfected cells. These observations prompted us to study the tumorigenic and metastatic potential of melanoma cells expressing KCREB.
To determine the tumorigenicity of the KCREBtransfected cells, we injected 1610 6 cells subcutaneously (s.c.) into athymic BALB/c-nude mice ( Figure  1 ). Tumor growth was monitored once a week for a period of 60 days. Figure 1 shows that parental MeWo cells grew progressively in all mice injected, producing tumors of 13 mm in mean diameter by 60 days. These results are in agreement with previously published data (Welch et al., 1991; Luca et al., 1995) . In contrast, K-2 and K-10 cells grew slowly and formed smaller tumors (6 mm in mean diameter) 60 days after injection. The ability of tumor cells to grow and form colonies in agarose correlates with their in vivo proliferative and metastatic capacity (Li et al., 1989) . KCREB-transfected cells formed smaller and fewer colonies in agar than their parental and neo-transfected counterparts (Yang et al., 1996) , suggesting that the CREB transcription factor in¯uences the metastatic capability of melanoma cells. Here we analysed the metastatic potential of KCREB-transfected cells in an experimental lung metastasis assay. To that end, 1610 6 cells were injected into the lateral tail vein of BALB/c nude mice and 80 days later the number of lung metastases was counted. We found that the two KCREBtransfected clones, K-2 and K-10 exhibited twofold and sixfold reduction in their ability to produce lung metastases respectively when compared with parental and neo-transfected cells (Table 1 ). The median KCREB eect on melanoma cell migration through Matrigel-coated ®lters
MeWo cells were compared before and after transfection with the KCREB mutant gene to assess the role of CREB in melanoma cell penetration through the basement membrane, an important component in the process of tumor invasion and metastasis (Bernstein and Liotta, 1994; Lester and McCarthy, 1992) . MeWo parental and neo-transfected cells exhibited high potential to penetrate through Matrigel-coated ®lters (Table 2 ). In contrast, KCREB-transfected cells K-2 and K-10 displayed 10 ± 20-fold decrease (P50.001) in their ability to invade through these ®lters. These studies show that expression of KCREB by melanoma cells decreased their capacity to penetrate through the basement membrane and suggest that CREB and its associated proteins have a speci®c role in the migration and invasion of melanoma cells.
Decrease in MMP-2 activity and expression in KCREBtransfected cells
The metastatic potential of tumor cells depends on proper vascularization of the tumor and its ability to degrade type IV collagen. Downregulation or deactivation of type IV collagenase (72 kDa, MMP-2, gelatinase A) may account for the decrease in invasiveness and metastatic potential of KCREBtransfected cells. To test this hypothesis, we analysed the activity of type IV collagenase (MMP-2) in parental MeWo, neo-transfected and the KCREBtransfected clones (Figure 2a ). Supernatants from these cells were analysed for collagenase activity by zymography (Ballin et al., 1988) . Collagenase activity in the supernatants was normalized to cell number as we have previously described (Singh et al., 1995) . The results depicted in Figure 2a show a 2.2 and 1.85-fold decrease (determined by densitometry) in MMP-2 collagenase activity in K-10 cells as compared with parental MeWo (lane 1) and neo-transfected cells (lane 2), while the K-2 cells displayed a nine and sixfold decrease when compared to parental MeWo and neotransfected cells, respectively. We did not observe any change in the activity of the 92 kDa (MMP-9) collagenese. The decrease in MMP-2 activity in KCREB-transfected cells was accompanied by a 2.5-fold decrease in MMP-2 mRNA transcript in K-2 cells and by a 3.5-fold decrease in K-10 cells (Figure 2b ) as compared with parental and neo-transfected cells.
Eect of KCREB on the MMP-2 promoter
The MMP-2 promoter contains a CRE element at position 7374 to 7366 with respect to the transcription initiation site (Huhtala et al., 1990) . To examine the eect of KCREB on MMP-2 transcription, the MMP-2 promoter (7393 to +290) was cloned upstream of the CAT reporter gene and transfected into neo-transfected MeWo, K-2, and K-10 cells.
Forty-eight hours after transfection, cells extracts were prepared and equivalent amounts of extracts exhibiting the same b-gal activity were tested for CAT activity. As Figure 3 shows, CAT activity driven by the MMP-2 promoter was signi®cantly inhibited by 14-and 45-fold in the KCREB transfected K-10 and K-2 cells, respectively, compared with neo-transfected cells (compare lane 3 in MeWo-neo versus K-10 and K-2). CAT activity driven by the SV40 promoter was the same in all three cell populations and served as an 2610 5 ) were added to the upper compartment of the Boyden chamber. Fibroblast-conditioned medium was placed in the lower compartment as a source of chemattractant. After 6 h incubation, the cells on the lower surface of the ®lter were stained and counted Figure 3 ). We have previously demonstrated that unlike nuclear extracts from MeWo parental and neo-transfected cells, nuclear extracts from K-2 and K-10 cells fail to bind to the CRE element on a gel shift mobility assay (Yang et al., 1996) . Together, these data demonstrate that the transcription factor CREB and its associated proteins are involved in the transcription of the MMP-2 gene.
KCREB downregulates MCAM/MUC18
The cell surface glycoprotein MCAM (previously known as MUC18), a member of the immunoglobulin superfamily, is associated with tumor progression and melanoma metastasis (Lehmann et al., 1989) . Indeed, we demonstrated that MCAM expression directly correlates with the metastatic potential of human melanoma cells in nude mice (Luca et al., 1993) . Furthermore, enforced expression of MCAM in MCAM-negative cells rendered them highly tumorigenic and increased their metastatic potential in vivo (Xie et al., 1997) . The promoter of the MCAM gene contains the TGAAGTCA motif, which is the binding site for the CREB transfection factor (Sers et al., 1993) . KCREB may aect the expression of MCAM and provide an additional mechanism for the observed inhibition of tumor growth and metastasis of the KCREB-transfected cells. To test this hypothesis, we analysed the expression of MCAM following KCREB transfection. The results depicted in Figure 4 show that MCAM expression was inhibited by 2.5-fold and by 3.3-fold in K-2 and K-10 respectively, as compared to parental and control neo-transfected cells.
Discussion
We have previously demonstrated that expression of dominant-negative CREB (KCREB) in human melanoma cells reduces their resistance to radiation (Yang et al., 1996) . Moreover, the KCREB-transfected cells display a marked decrease in their ability to form colonies in agar, suggesting that CREB may be involved in tumorigenicity and metastatic potential of human melanoma cells. In the present study we show that expression of KCREB in highly metastatic MeWo cells inhibits tumor growth and metastasis in nude mice.
The dominant-negative construct used in this study displays an altered DNA-binding activity owing to a single base pair change, from arginine to leucine at position 287. This arginine is conserved within the basic region of the leucine zipper DNA-binding motif, in more than 30 dierent members of the AP1/ATF family of transcription factors (Ellenberger et al., 1992) . The KCREB protein is expected to yield proper heterodimerization with AP1/CRE-binding factors, however, due to its poor anity to DNA, CREB-associated proteins would confer an altered transcriptional activity. As a result, expression of the dominant negative CREB will quench any of the known CREBassociated proteins including members of the ATF (Abdel-Malek et al., 1993; Wanda et al., 1991) and AP1 families (Hai and Curran, 1991) and the 265 kDa CREB-binding protein (CBP) that links CREB to the basal transcription machinery through its association with TFIIB (Kwok et al., 1994) . In the KCREB clones characterized in the present study, endogenous CREB may still interact with the CRE target sequences, yet, due to the quenching properties of KCREB, endogenous CREB is likely to associate with dierent transcription factors. Such a change would result in dierent size complexes and modi®ed transcriptional activities. Our results support this mechanism since nuclear extracts from the KCREB transfected clones K-2 and K-10 failed to react with the CRE element on the gel mobility shift assay, while CRE-CREB complexes were observed in nuclear extracts from parental and neo-transfected Me-Wo cells (Yang et al., 1996) .
The process of metastasis includes detachment of tumor cells from the primary tumor mass, degradation of and migration through the surrounding connective tissue into the vascular system, transport and extravasation (Aslakson and Miller, 1992; Bernstein and Liotta, 1994 ). An important factor in regulating dissemination is the ability of the tumor cells to adhere to and migrate through the extracellular matrix Lester and McCarthy 1992) . Highly metastatic cells are more motile than less metastatic cells (Patrin et al., 1991) . In our studies, The invasive potential of a tumor depends among many factors on its ability to degrade type IV collagen. Indeed, activation of the 72 kDa type IV collagenase (MMP-2, gelatinase A) provides a mechanism to explain the increased metastatic potential of human melanoma cells (Singh et al., 1995) . In this study, we showed that expression of dominant-negative KCREB in melanoma cells markedly reduces MMP-2 mRNA exression and activity (Figure 2) . Our results demonstrate that KCREB directly regulates the transcription of the MMP-2 gene (Figure 3) , possibly via the CRE element within the MMP-2 promoter (Huhtala et al., 1990) . This regulation could be explained by the observation that unlike nuclear extracts from parental MeWo and neo-transfected cells, nuclear extracts from KCREB-transfected cells did not form DNA-protein complexes with the CRE binding motif on an EMSA gel (Yang et al., 1996) . Downregulation of MMP-2 expression and activity might be one of the mechanisms to account for the descrease in metastatic potential of the KREB-transfected cells. Indeed, it has recently been shown that MMP-2 (gelatinase A) activity directly modulates melanoma cell adhesion and spreading to extracellular matrix (ECM) (Ray and Stetler-Stevenson, 1995) . These results imply that in addition to contributing to proteolysis of ECM components, MMP-2 also proteolyses cell surface components that mediate attachment of melanoma cells to the ECM. As such, MMP-2 may modulate cell adhesion and facilitate cell migration and invasion. The crucial role of CREB and its associated proteins in melanoma adhesion and invasion is further supported by the observation that phorbol ester induces rapid attachment and spreading of melanoma cells ( Vanleeuwen et al., 1994 ) .
Another tumor cell property that is essential for metastasis is the expression of cell adhesion molecules (CAMs) which mediate cell-to-cell or cell-to-matrix interactions. MCAM, previously known as MUC18, is a newly recognized CAM belonging to the immunoglobulin superfamily (Lehmann et al., 1989) . MCAM is strongly expressed by advanced primary and metastatic melanomas but is weaker and less frequent in nevus cells. We have recently demonstrated that enforced expression of MCAM in MCAM-negative cells rendered them highly tumorigenic and increased their metastatic potential in nude mice (Xie et al., 1997) . The transfected cells displayed increased homotypic aggregation, increased attachment to human endothelial cells, decreased ability to adhere to laminin, and increased invasiveness through Matrigel-coated ®lters. These functional changes attributed to the expression of MCAM may underlie the contribution of MCAM to the malignant phenotype of human melanoma (Xie et al., 1997) . Here we show that KCREB transfected cells displayed 2.5-to 3.5-fold decrease in MCAM mRNA transcript expression, thus providing an additional mechanism for the inhibition of tumorigenicity and metastatic potential of the KCREB-transfected clones.
In summary, our data demonstrate that the transcription factor CREB and its associated proteins are involved in MMP-2 and MCAM/MUC18 gene transcription. Since both genes are involved in the development of malignant melanoma these results suggest that CREB and its associated proteins may play an important role in the acquisition of the metastatic phenotype of human melanoma cells.
Materials and methods

Cell lines
Human melanoma MeWo cells were kindly provided by Dr S Ferrone (New York Medical College) and maintained in RPMI, supplemented with 5% fetal bovine serum, Lglutamine and antibiotics. K-2 and K-10 clones were maintained in the same medium supplemented with G418 (200 mg/ml). All cells were grown at 378C with 5% CO 2 .
Transfection of KCREB into MeWo cells and selection of K-clones
Transfection of MeWo melanoma cells with the pRSV-KCREB construct and the isolation of the two clones K2 and K10 that express KCREB have been described previously (Yang et al., 1996) .
Animals
Male athymic BALB/c nude mice were purchased from the Animal Production Area of the National Cancer Institute, Frederick Cancer Research Faility (Frederick, MD). The mice were housed in laminar¯ow cabinets under speci®c pathogen-free conditions and used at 8 weeks of age. Animals were maintined in facilities approved by the American Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the United States Department of Agriculture, Department of Health and Human Services, and National Institutes of Health.
Northern blot analysis
mRNA was isolated by FastTrack 2.0 (Invitrogen, San Diego, CA) according to the manufacturer's instructions. Three microgrms of mRNA/lane was electrophoresed on a 1% denaturing formaldehyde/agarose gel, electrotransferred at 0.6 amp to NYTRAN nylon transfer membrane (Schleicher & Schuell, Keene, NH) and u.v. cross-linked with 120 000 mJ/cm 2 using a u.v. Stratalinker 1800 (Stratagene, LaJolla, CA). Hybridizations were performed as previously described (Singh et al., 1995) . Nylon ®lters were washed three times at 55 ± 608C with 30 mM NaCl -3 mM sodium citrate (pH 7.2) ± 0.1% SDS (w/v). The cDNA probes used in these analyses were a 1.3 kb PstI cDNA fragment corresponding to rat glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a 1 kb EcoRI cDNA fragment from the plasmid pH3a representing the human 72 kDa gelatinase (72 kDa type IV collagenase, gelatinase A, MMP-2) gene (courtesy of WG Stetler-Stevenson, Laboratory of Pathology, National Cancer Institute, Bethesda, MD) and a 1.2 kb SstI ± PstI cDNA fragment of the human MCAM/MUC18 gene (Lehmann et al., 1989) . Each cDNA fragment was puri®ed by agarose gel electrophoresis, recovered using Qiaquick (QIAGEN, Chatsworth, CA), and radiolabeled by the random primer technique using a 32 P-deoxyribonucleotide triphosphates. mRNA expression was quanti®ed in the linear range of the ®lm on a Personal Densitometer using the ImageQuant TM software program (Molecular Dynamics, Sunnyvale, CA). Each sample measurement was calculated as the ratio of area between the 3.1 kb MMP-2-speci®c mRNA transcript and the 1.3 kb glyceraldehyde 3-phosphate dehydrogenase transcript.
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Tumor cell injections
To prepare tumor cells for inoculation, cells in exponential growth phase were harvested by brief exposure to 0.25% trypsin-0.2% EDTA solution (w/v). The¯ask was sharply tapped to dislodge the cells, and supplemented medium was added. The cell suspension was pipetted to produce a single-cell suspension. The cells were washed and resuspended in Ca 2+ -and Mg 2+ -free HBSS to the desired cell concentration. Cell viability was determined by trypan-blue exclusion, and only single-cell suspensions of more than 90% viability were used. s.c. tumors were produced by injecting 1 610 6 tumor cells in 0.2 ml HBSS over the right scapular region. Growth of s.c. tumors was monitored by examination of the mice every day and weekly measurement of tumors with calipers. The mice were killed 2 months after injection, and tumors were processed for hematoxylin and eosin staining.
For experimental lung metastasis 1610 6 tumor cells-0.2 ml of HBSS were injected into the lateral tail vein of nude mice. The mice were killed ater 80 days and the lungs were removed, washed in water, and ®xed with Bouin's solution for 24 h to facilitate counting of tumor nodules as we described previously. (Radinsky et al., 1994; Huang et al., 1996a,b) . The number of surface tumor nodules was counted under a dissecting microscope. Sections of the lungs were stained with hemotoxylin and eosin to con®rm that the nodules were melanoma and to identify micrometastasis.
Zymography
Collagenolytic activity was determined on substrateimpregnated gels according to Ballin et al. (1998) , with minor modi®cations. Five610 3 cells/well were replated into a 96-well culture plate. After 24 h of cell adherence, cultures were washed and refed with fresh medium. Culture supernatants were collected and analysed for collagenase activity. Samples of culture media were separated on gelatin-impregnated (1 mg/ml; Difco, Detroit, MI) SDS-8% polyacrylamide gels under nonreducing conditions, followed by 30 min of shaking in 2.5% Triton X-100 (BDH, UK). The gels were then incubated for 16 h at 378C in 50 mM Tris, 0.2 M NaCl, 5 mM CaCl 2 , and 0.02% Brij 35 (w/v) at pH 7.6. At the end of the incubation, gels were stained with 0.5% Coomassie G 250 (Bio-Rad, Richmond, CA) in methanol:acetic acid : H 2 O (30 : 10 : 60). The intensity of the various bands was determined on a computerized densitometer (Molecular Dynamics type 300A).
DNA transfection and CAT assays
Using the Lipofectin protocol (GIBCO BRL, Gaithersburg, MD), we transfected the basic CAT expression vector with minimal TK promoter sequences (pCAT-basic), positive control plasmid with SV40 promoter and enhancer (pCAT-control, Promega, Madison, WI) or CAT plasmid driven by the MMP-2 promoter into MeWo, neo-transfected and KCREB-transfected cells. One copy of the human MMP-2 promoter region spanning nucleotides 7393 to +290 (Huhtala et al., 1990) was ligated upstream of the basic CAT expression vector. The human MMP-2 promoter segment was generated by the polymerase chain reaction (PCR) using primers encompassing both ends of this domain and`sticky ends' of HindIII and XbaI, respectively, as previously described for the p53 promoter (Hudson et al., 1995) . We transfected 3.0610 6 cells with 2.5 mg of the reporter CAT constructs and 2.5 mg of a b-galactosidase (b-gal) expression plasmid. The b-gal expression vector is controlled by the viral thymidine kinase promoter (Clontech, Palo Alto, CA). After 48 h, extracts were prepared from all plates, normalized for b-gal activity, and assayed for CAT activity (Gorman et al., 1982) as we described previously (Hudson et al., 1995) . Each assay was repeated at least three times; there was less than 10% variation among individual transfections. The results of the CAT assay were quanti®ed by densitometry (Personal Densitometer, Molecular Dynamics, Sunnyvale, CA).
Invasion assay through Matrigel
Polyvinylpyrrolidone-free polycarbonate ®lters (8 mm pore size, nucleopore, Pleasanton, CA) were coated with a mixture of basement membrane components (Matrigel, 25 mg ®lter) and placed in modi®ed Boyden chambers. The cells (2610 5 ) were released from their culture dishes by short exposure to EDTA (1 mM), centrifuged, resuspended in 0.1% BSA/DMEM, and placed in the upper compartment of the Boyden Chamber. Fibroblast-conditioned medium was placed in the lower compartment as a source of chemoattractants. After incubation for 6 h at 378C, the cells on the lower surface of the ®lter were stained with Di-Quick (American Scienti®c Products, McFaw, IL) and quanti®ed with an image analyser (Optomax V) attached to an Olympus CK2 microscope. The date were expressed as the average number of cells on the lower surface of the ®lter from each of the three experiements +s.e.m.
